
Dr. Nitin Singhal is a highly experienced onco-surgeon in Ahmedabad, specializing in the treatment and surgical management of prostate cancer and other urological cancers.
With over 15 years of expertise in surgical oncology, he combines advanced techniques like robotic surgery, minimally invasive procedures, and HIPEC with a patient-centered approach to deliver the best possible outcomes.
Prostate cancer develops in the prostate gland, a small walnut-shaped organ located below the bladder in men, responsible for producing seminal fluid.
It is one of the most common cancers in men, especially those over the age of 50. While prostate cancer often grows slowly and may not cause symptoms in its early stages, some types are more aggressive and can spread quickly if not treated.
Common warning signs include frequent urination, difficulty starting or stopping urination, weak urine flow, blood in urine or semen, pelvic pain, and erectile dysfunction.
Since early prostate cancer may not show noticeable symptoms, regular PSA (Prostate-Specific Antigen) blood tests and digital rectal exams are important for early detection.
Dr. Nitin Singhal provides comprehensive prostate cancer care in Ahmedabad, offering advanced and personalised treatments tailored to each patient's stage and condition.
Treatment options may include:
Understanding the stage of prostate cancer helps determine the most appropriate treatment approach.
At this very early stage, prostate cancer is confined to the prostate gland. The tumour is usually small, slow-growing, and may not cause any symptoms. It is often detected during a routine PSA (Prostate-Specific Antigen) blood test or digital rectal exam. Many patients at this stage may not require immediate aggressive treatment; instead, active surveillance or appropriate local treatment can be considered.
The tumour remains inside the prostate but may be larger and more noticeable on imaging or biopsy. Depending on the aggressiveness of the cancer cells, treatment may involve radical prostatectomy, robotic-assisted surgery, or radiation therapy. Some men may also benefit from a combination of hormone therapy and radiation.
At this stage, prostate cancer spreads beyond the prostate capsule to nearby tissues, such as the seminal vesicles, but has not yet reached distant organs. Treatment may involve a combination of surgery, radiation therapy, and hormone therapy, depending on the patient's health, age and cancer aggressiveness.
This is the most advanced stage, where cancer spreads to lymph nodes, bones, lungs, liver, or other distant organs. Patients may experience bone pain, fatigue, unexplained weight loss, or systemic symptoms. Treatments such as androgen deprivation therapy, chemotherapy, targeted therapy, immunotherapy and palliative radiation may be used to control the disease and improve quality of life.
Treatment is selected according to the stage, aggressiveness and individual characteristics of the prostate cancer.
Active surveillance and regular monitoring may be considered for selected very slow-growing or low-risk prostate cancers.
Radical prostatectomy involves surgical removal of the entire prostate gland and may be recommended for selected localised prostate cancers.
Robotic-assisted prostate surgery provides the surgeon with enhanced visualisation and precise instrument control during selected prostate cancer procedures.
Radiation therapy uses high-energy radiation to target prostate cancer cells. Treatment may include external beam radiation or brachytherapy in selected cases.
Hormone therapy can reduce testosterone levels that may fuel the growth of prostate cancer and may be used in selected stages of the disease.
Chemotherapy and targeted treatments may be considered for advanced or treatment-resistant prostate cancer, depending on the patient's condition.
Robotic-assisted prostatectomy is a minimally invasive surgical approach used for selected prostate cancer patients. The robotic platform provides the surgeon with enhanced visualisation and precise instrument control.
It can help surgeons perform complex procedures through smaller incisions and may support faster recovery in appropriately selected patients.
Answers to common questions about symptoms, robotic surgery, treatment and prostate cancer risk.
Early prostate cancer often has no clear symptoms. In later stages, men may experience urinary problems, blood in urine or semen, erectile dysfunction and pelvic discomfort.
Robotic-assisted prostatectomy can provide precise surgical control and minimally invasive treatment for selected patients with localised prostate cancer. Suitability depends on the patient's cancer stage, overall health and individual clinical factors.
When detected at an early stage, prostate cancer can often be treated effectively with options such as surgery or radiation therapy. More advanced disease may require a combination of hormone therapy, chemotherapy, targeted treatment or other systemic therapies to control the disease.
Risk increases with age, particularly in men over 50. A family history of prostate cancer and certain genetic or demographic factors can also increase risk. Men with higher-risk factors should discuss appropriate screening with a healthcare professional.
PSA stands for Prostate-Specific Antigen. A PSA blood test measures the level of this protein in the blood and may be used as part of prostate cancer evaluation and screening.
Advanced prostate cancer may be managed with treatments such as androgen deprivation therapy, chemotherapy, targeted therapy, radiation and other systemic treatments. Treatment depends on the extent and characteristics of the cancer.
If you or a loved one has been diagnosed with prostate cancer or is experiencing concerning symptoms, consult an experienced oncology specialist to understand the available treatment options.
Dr. Nitin Singhal has been recognised for his contribution to cancer care and surgical oncology, reflecting his commitment to advanced surgical techniques, clinical excellence and patient-centred care.
Surgical oncology training from Tata Memorial Hospital, Mumbai.
Expertise across complex and multidisciplinary cancer surgery.
Honoured for excellence in healthcare and surgical oncology.
Focus on evidence-based and personalised cancer treatment.
Recognition that reflects a continued commitment to excellence in cancer care.